PoC Agreement Signed with A.Dot Cure for "Heart to Voice" Voice Analysis Solution

Research is underway at hospitals in Busan to assess the risk of heart failure by using artificial intelligence (AI) to analyze subtle changes in people's voices. Attention is focused on whether noninvasive monitoring technology using voice data can be put to use in real-world medical settings.


Busan Bumin Hospital and Haeundae Bumin Hospital signed an agreement on November 19 with A.Dot Cure Co., Ltd., a voice AI-based digital healthcare company, to conduct a proof-of-concept (PoC) study of its cardiovascular health monitoring solution, "Heart to Voice."


The study was designed to monitor changes in health risks among people at high risk of cardiovascular disease using voice data, analyze their association with existing clinical test indicators, and assess the technology's potential for use in medical settings.


"Heart to Voice" uses AI to analyze subtle features in the voice to identify cardiovascular health risks and changes in health status. Its noninvasive voice-analysis approach could potentially be used for the early detection of cardiovascular disease risks and ongoing health monitoring.


The proof-of-concept study will involve 100 people at high risk of heart failure who visit the health screening centers at the two hospitals, meet the selection criteria, and consent to participate in the study.


The researchers plan to collect participants' voice data and analyze its association with monitoring alerts generated by the AI solution and the results of NT-proBNP blood tests. NT-proBNP is a substance whose blood concentration may rise when the heart is under strain, and it is used in the diagnosis and assessment of cardiovascular diseases, including heart failure.


Through the study, the two institutions aim to assess the potential for voice AI technology to be used in medical settings based on data collected in real-world health screening environments, while laying the groundwork for advancing cardiovascular health risk monitoring technology and research and development in digital healthcare.


Jung Heungtae, chairman of Bumin Hospital Group, said, "This is meaningful because it applies new medical AI technology in an actual health screening setting and verifies its potential applications."



He said, "We will contribute to the advancement of medical services and the creation of a patient-centered healthcare environment through research collaboration on various digital healthcare technologies."

Busan Bumin Hospital and Haeundae Bumin Hospital are signing an agreement with A.Dot Cure, a voice AI-based digital healthcare company, to conduct a proof-of-concept (PoC) study of its cardiovascular health monitoring solution, "Heart to Voice."

Busan Bumin Hospital and Haeundae Bumin Hospital are signing an agreement with A.Dot Cure, a voice AI-based digital healthcare company, to conduct a proof-of-concept (PoC) study of its cardiovascular health monitoring solution, "Heart to Voice."

View original image


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing